Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED MedTech announces the definitive acquisition of Global Dental Technology Platform, ZimVie, in an approximately $730 million take-private deal.

ARCHIMED  buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market

 October

 15, 

2024

ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices

 September

 11, 

2024

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

 September

 4, 

2024

ARCHIMED acquires Irrimax, market leader in anti-microbial wound irrigation solutions

 August

 28, 

2024

Majority owner ARCHIMED and its partners fund three add-on acquisitions by diversified European health safety testing company, CARSO

 May

 6, 

2024

ARCHIMED concludes successfully its £203 million take-private bid for drug development software leader Instem

 November

 27, 

2023

< 1 2 3 4 5 … 16 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top